104 related articles for article (PubMed ID: 30816603)
1. Evaluating a risk assessment tool to improve triaging of patients to colonoscopies.
Elliott TM; Lord A; Simms LA; Radford-Smith G; Valery PC; Gordon LG
Intern Med J; 2019 Oct; 49(10):1292-1299. PubMed ID: 30816603
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of a risk assessment tool to improve clinical triage accuracy for colonoscopic investigations.
Lord AR; Simms LA; Brown A; Hanigan K; Krishnaprasad K; Schouten B; Croft AR; Appleyard MN; Radford-Smith GL
BMC Cancer; 2018 Feb; 18(1):229. PubMed ID: 29486733
[TBL] [Abstract][Full Text] [Related]
3. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
4. REducing Colonoscopies in patients without significant bowEl DiseasE: the RECEDE Study - protocol for a prospective diagnostic accuracy study.
Bradley C; Hee SW; Andronis L; Persaud K; Hull MA; Todd J; Taylor-Phillips S; Smith S; Constable R; Waugh N; Arasaradnam RP;
BMJ Open; 2022 Mar; 12(3):e058559. PubMed ID: 35354626
[TBL] [Abstract][Full Text] [Related]
5. Validation of Australian and Victorian guidelines for colonoscopy triage.
Emery JD; Kyriakides M; Faragher I; Ewing H; Moss A
Intern Med J; 2021 Sep; 51(9):1457-1462. PubMed ID: 33462903
[TBL] [Abstract][Full Text] [Related]
6. Clinical triage for colonoscopy is useful in young women.
Williamson KD; Steveling K; Holtmann G; Schoeman M; Andrews JM
Intern Med J; 2015 May; 45(5):492-6. PubMed ID: 25644364
[TBL] [Abstract][Full Text] [Related]
7. Cost and time savings from a rapid access model of care using transient elastography to screen and triage patients with chronic Hepatitis C infection.
Whitty JA; Tallis C; Nguyen KH; Scuffham PA; Crosland P; Hewson K; Pai Mangalore R; Black M; Holtmann G
J Med Econ; 2014 Feb; 17(2):159-65. PubMed ID: 24246063
[TBL] [Abstract][Full Text] [Related]
8. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
9. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
10. Faecal calprotectin delivers on convenience, cost reduction and clinical decision-making in inflammatory bowel disease: a real-world cohort study.
Motaganahalli S; Beswick L; Con D; van Langenberg DR
Intern Med J; 2019 Jan; 49(1):94-100. PubMed ID: 29962008
[TBL] [Abstract][Full Text] [Related]
11. Budget-impact model for colonoscopy cost calculation and comparison between 2 litre PEG+ASC and sodium picosulphate with magnesium citrate or sodium phosphate oral bowel cleansing agents.
Gruss HJ; Cockett A; Leicester RJ
J Med Econ; 2012; 15(4):758-65. PubMed ID: 22364285
[TBL] [Abstract][Full Text] [Related]
12. Triage May Improve Selection to Colonoscopy and Reduce the Number of Unnecessary Colonoscopies.
Petersen MM; Ferm L; Kleif J; Piper TB; Rømer E; Christensen IJ; Nielsen HJ
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32932734
[TBL] [Abstract][Full Text] [Related]
13. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.
Lew JB; St John DJB; Xu XM; Greuter MJE; Caruana M; Cenin DR; He E; Saville M; Grogan P; Coupé VMH; Canfell K
Lancet Public Health; 2017 Jul; 2(7):e331-e340. PubMed ID: 29253458
[TBL] [Abstract][Full Text] [Related]
14. 'Why don't I need a colonoscopy?' A novel approach to communicating risks and benefits of colorectal cancer screening.
Emery JD; Pirotta M; Macrae F; Walker JG; Qama A; Jenkins M; Boussioutas A
Aust J Gen Pract; 2018 Jun; 47(6):343-349. PubMed ID: 29966179
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
16. Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme.
Nnoaham KE; Lines C
Gut; 2008 Sep; 57(9):1238-45. PubMed ID: 18441004
[TBL] [Abstract][Full Text] [Related]
17. Colonoscopy requirements of population screening for colorectal cancer in New Zealand.
Green T; Richardson A; Parry S
N Z Med J; 2012 Jun; 125(1356):85-95. PubMed ID: 22729063
[TBL] [Abstract][Full Text] [Related]
18. A novel pathway for investigation of colorectal symptoms with colonoscopy or computed tomography colonography.
Sanders AD; Stevenson C; Pearson J; Burt M; McGeoch G; Hudson B; Eglinton TW
N Z Med J; 2013 Sep; 126(1382):45-57. PubMed ID: 24154769
[TBL] [Abstract][Full Text] [Related]
19. Value-Based ST-Segment-Elevation Myocardial Infarction Care Using Risk-Guided Triage and Early Discharge.
Ebinger JE; Strauss CE; Garberich RR; Bradley SM; Rush P; Chavez IJ; Poulose AK; Porten BR; Henry TD
Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004553. PubMed ID: 29654000
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
